المؤلفون: Constantine-Cooke, N, Vestergaard, M V, Plevris, N, Monterrubio-Gómez, K, Ramos Belinchón, C, Ong, S, Elford, A T, Gros, B, Sazonovs, A, Jones, G R, Jess, T, Vallejos, C A, Lees, C W

المصدر: Journal of Crohn's and Colitis ; volume 19, issue Supplement_1, page i1563-i1565 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjae190.0991
https://academic.oup.com/ecco-jcc/article-pdf/19/Supplement_1/i1563/61545689/jjae190.0991.pdf

المؤلفون: Jones, G R, Drury, B, Hegarty, L, Alegbe, T, Krzak, M, Raine, T, Byrne, A, Anderson, C, Ho, G T, Bain, C

المصدر: Journal of Crohn's and Colitis ; volume 19, issue Supplement_1, page i286-i287 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjae190.0151
https://academic.oup.com/ecco-jcc/article-pdf/19/Supplement_1/i286/61540672/jjae190.0151.pdf

المؤلفون: Harris, B, Alegbe, T, Ramirez-Navaro, L, Tutert, M, Krzak, M, Ozols, M, Ghouraba, M, Strickland, M, Wana, N, Hu, M, Ostermayer, J, McIntyre, R, Cotobal Martin, C, Fachal, L, Jones, G R, Raine, T, Anderson, C

المصدر: Journal of Crohn's and Colitis ; volume 19, issue Supplement_1, page i5-i6 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjae190.0003
https://academic.oup.com/ecco-jcc/article-pdf/19/Supplement_1/i5/61540703/jjae190.0003.pdf

المؤلفون: Gros, B, Plevris, N, Constantine-Cooke, N, Lyons, M, O’Hare, C, Noble, C, Arnott, I D, Jones, G R, Lees, C W, Derikx, L A A P

المصدر: Journal of Crohn's and Colitis ; volume 17, issue Supplement_1, page i876-i876 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjac190.0875
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i876/51512707/jjac190.0875.pdf

المؤلفون: Jones, G R, Hegarty, L, T'Jonck, W, Adams, C, Drury, B, Byrne, A, Ho, G T, Bain, C

المصدر: Journal of Crohn's and Colitis ; volume 17, issue Supplement_1, page i93-i94 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjac190.0068
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i93/51508526/jjac190.0068.pdf

المؤلفون: Lin, S, Kennedy, NA, Saifuddin, A, Sandoval, DM, Reynolds, CJ, Seoane, RC, Kottoor, SH, Pieper, FP, Lin, K-M, Butler, DK, Chanchlani, N, Nice, R, Chee, D, Bewshea, C, Janjua, M, McDonald, TJ, Sebastian, S, Alexander, JL, Constable, L, Lee, JC, Murray, CD, Hart, AL, Irving, PM, Jones, G-R, Kok, KB, Lamb, CA, Lees, CW, Altmann, DM, Boyton, RJ, Goodhand, JR, Powell, N, Ahmad, T

مصطلحات موضوعية: BNT162 Vaccine, COVID-19, COVID-19 Vaccines, ChAdOx1 nCoV-19, Inflammatory Bowel Diseases, Infliximab, SARS-CoV-2, T-Lymphocytes, Tumor Necrosis Factor Inhibitors, Viral Vaccines

وصف الملف: 1379-

Relation: https://www.ncbi.nlm.nih.gov/pubmed/35296643; https://www.clarityibd.org/; https://github.com/exeteribd/clarityibd-public; Nat Commun, 13(1); ScopusID: 56404713200 (Bewshea, Claire); ScopusID: 54393616700 (McDonald, Timothy J); Vol. 13(1), article 1379; http://hdl.handle.net/10871/129445; Nature Communications

الاتاحة: http://hdl.handle.net/10871/129445
https://doi.org/10.1038/s41467-022-28517-z

المؤلفون: Alexander, J. L., Liu, Z., Muñoz Sandoval, D., Reynolds, C., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Castro Seoane, R., Anand, N., Nice, R., Bewshea, C., D'Mello, A., Constable, L., Jones, G. R., Balarajah, S., Fiorentino, F., Sebastian, S., Irving, P. M., Hicks, L. C., Williams, H. R. T., Kent, A. J., Linger, R., Parkes, M., Kok, K., Patel, K. V., Teare, J. P., Altmann, D. M., Goodhand, J. R., Hart, A. L., Lees, C. W., Boyton, R. J., Kennedy, N. A., Ahmad, T., Powell, N.

Relation: https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(22)00005-X; Lancet Gastroenterol Hepatol. 2022 Sep 8:S2468-1253(22)00274-6. doi:10.1016/S2468-1253(22)00274-6.; https://rde.dspace-express.com/handle/11287/622614; The lancet. Gastroenterology & hepatology; PMC9458592 accommodation and travel to BSG 2019, outside the submitted work. NAK reports grants from AbbVie, Biogen, Celgene, Celtrion, Galapagos, MSD, Napp, Pfizer, Pharmacosmos, Roche, and Takeda; consulting fees from Amgen, Bristol Myers Squibb, Falk, Janssen, Mylan, Pharmacosmos, Galapagos, Takeda, and Tillotts; personal fees from Allergan, Celltrion, Falk, Ferring, Janssen, Pharmacosmos, Takeda, Tilllotts, and Galapagos; and support for attending meetings from AbbVie, Falk, and Janssen, outside the submitted work. AS has received travel expense support from Janssen. SS reports grants from Takeda, AbbVie, Tillots Pharma, Janssen, Pfizer, and Biogen; and personal fees from Takeda, AbbVie, Janssen, Pharmacocosmos, Biogen, Pfizer, Tillots Pharma, and Falk Pharma, outside the submitted work. ALH reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, AstraZeneca, Atlantic, Bristol Myers Squibb, Celltrion, Falk, Galapogos, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire, and Takeda; global steering committee for Genentech; support for attending meetings from AbbVie, Takeda, and Janssen; and participation on a data safety monitoring board or advisory board for AbbVie, AstraZeneca, Atlantic, Bristol Myers Squibb, Galapogos, Janssen, Pfizer, and Takeda. PMI reports grants and personal fees from Celltrion, Takeda, Pfizer, Galapagos; grants from MSD; and personal fees from Gilead, AbbVie, Janssen, Bristol Myers Squibb, Lilly, and Arena, outside the submitted work. MP receives unrestricted educational grants from Pfizer for genetic analyses to support the IBD BioResource, and speaker fees from Janssen. GRJ has received grants from Wellcome Trust and ECCO; speaker fees from Takeda, Ferring, and Janssen; and support for attending meetings or travel from Ferring. KK reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Janssen and Ferring; support for attending meetings or travel from Janssen and Takeda; and participation on a data safety monitoring board or advisory board for Janssen and Predict Immune. SB reports funding from Ferring and Dr Falk for accommodation, travel, and meeting fees. KVP reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Dr Falk, Janssen, PreddictImmune, and Takeda; support for attending meetings or travel from AbbVie, Ferring, Janssen, and Tillots; and participation on a data safety monitoring board or advisory board for AbbVie, Galapagos, and Janssen. AJK reports consulting fees from Janssen; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Pfizer and Takeda; support for attending meetings or travel from Janssen, Tillots, and Norgine; and participation on a data safety monitoring board or advisory board for AbbVie. LCH reports support for attending meetings or travel from AbbVie. CWL reports a Future Leaders Fellow award from UKRI; personal consulting fees from Galapagos, AbbVie, Takeda, Pfizer, Janssen, and Iterative Scopes; institutional consulting fees from Trellus Health; personal fees from Galapagos, AbbVie, Takeda, Pfizer, Janssen, GSK, Gilead, Fresnius Kabi, Ferring, and Dr Falk; and support for attending meetings from Galapagos, AbbVie, Takeda, Pfizer, Janssen, GSK, Gilead, Fresnius Kabi, Ferring, and Dr Falk. RJB and DMA are members of the Global T cell Expert Consortium and have consulted for Oxford Immunotec outside the submitted work. JRG reports grants from F Hoffmann-La Roche AG; grants from Biogen, Celltrion Healthcare, and Galapagos NV; and non-financial support from Immundiagnostik, during the conduct of the study. TA reports grant funding from Pfizer to his institution to deliver this study; grants from Celltrion, Roche, Takeda, Biogen, and Galapagos; and honoraria for lectures from Takeda and Roche, outside the submitted work. Financial support for the VIP study was provided as a research grant by Pfizer and NP is the principal investigator on this grant. NP has received research grants from Bristol Myers Squibb outside the submitted work; reports personal fees from Takeda, Janssen, Pfizer, Bristol Myers Squibb, AbbVie, Roche, Lilly, Allergan, and Celgene, outside the submitted work; and has served as a speaker or advisory board member for AbbVie, Allergan, Bristol Myers Squibb, Celgene, Falk, Ferring, Janssen, Pfizer, Tillotts, Takeda, and Vifor Pharma. All other authors declare no competing interests.

الاتاحة: https://doi.org/10.1016/s2468-1253(22)00274-6
https://rde.dspace-express.com/handle/11287/622614

المؤلفون: Alexander, J. L., Kennedy, N. A., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Castro Seoane, R., Liu, Z., Nice, R., Bewshea, C., D'Mello, A., Constable, L., Jones, G. R., Balarajah, S., Fiorentino, F., Sebastian, S., Irving, P. M., Hicks, L. C., Williams, H. R. T., Kent, A. J., Linger, R., Parkes, M., Kok, K., Patel, K. V., Teare, J. P., Altmann, D. M., Boyton, R. J., Goodhand, J. R., Hart, A. L., Lees, C. W., Ahmad, T., Powell, N.

مصطلحات موضوعية: Adolescent, Adult, Antibody Formation, BNT162 Vaccine, COVID-19/prevention & control, COVID-19 Vaccines, Case-Control Studies, ChAdOx1 nCoV-19, Humans, Inflammatory Bowel Diseases/drug therapy, Prospective Studies, SARS-CoV-2

Relation: https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(22)00005-X; Lancet Gastroenterol Hepatol. 2022 Apr;7(4):342-352. doi:10.1016/S2468-1253(22)00005-X. Epub 2022 Feb 4.; https://rde.dspace-express.com/handle/11287/622401; The lancet. Gastroenterology & hepatology; PMC8813209

الاتاحة: https://doi.org/10.1016/s2468-1253(22)00005-x
https://rde.dspace-express.com/handle/11287/622401

المؤلفون: Alexander, J, Kennedy, N, Ibraheim, H, Anandabaskaran, S, Saifuddin, A, Castro Seoane, R, Liu, Z, Nice, R, Bewshea, C, D’Mello, A, Constable, L, Jones, G R, Balarajah, S, Fiorentino, F, Sebastian, S, Irving, P M, Hicks, L, Williams, H, Kent, A, Linger, R, King, R, Parkes, M, Kok, K, Patel, K, Altmann, D, Boyton, R, Goodhand, J, Hart, A, Lees, C, Ahmad, T, Powell, N

المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i022-i023 ; ISSN 1873-9946 1876-4479

الاتاحة: https://doi.org/10.1093/ecco-jcc/jjab232.020
https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i022/42250252/jjab232.020.pdf

المؤلفون: Lin, S, Kennedy, N A, Saifuddin, A, Muñoz Sandoval, D, Reynolds, C J, Seoane, R C, Kottoor, S H, Pieper, F P, Lin, K M, Butler, D K, Chanchlani, N, Nice, R, Chee, D, Bewshea, C, Janjua, M, McDonald, T J, Sebastian, S, Alexander, J L, Constable, L, Lee, J C, Murray, C D, Hart, A L, Irving, P M, Jones, G R, Kok, K B, Lamb, C A, Lees, C W, Altmann, D M, Boyton, R J, Goodhand, J R, Powell, N, Ahmad, T

المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i023-i025 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.021
https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i023/42250112/jjab232.021.pdf

المؤلفون: Liu, Z., Alexander, J. L., Eng, K. Y., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Constable, L., Seoane, R. C., Bewshea, C., Nice, R., D'Mello, A., Jones, G. R., Balarajah, S., Fiorentino, F., Sebastian, S., Irving, P. M., Hicks, L. C., Williams, H. R. T., Kent, A. J., Linger, R., Parkes, M., Kok, K., Patel, K. V., Teare, J. P., Altmann, D. M., Boyton, R. J., Hart, A. L., Lees, C. W., Goodhand, J. R., Kennedy, N. A., Pollock, K. M., Ahmad, T., Powell, N.

مصطلحات موضوعية: JAK-inhibitor, anti-TNF, humoral immunity, immunisation

Relation: Liu Z, Alexander JL, Eng KY, Ibraheim H, Anandabaskaran S, Saifuddin A, et al. Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib. J Crohns Colitis. 2023.; Journal of Crohn's and colitis; https://hdl.handle.net/11287/623091

الاتاحة: https://hdl.handle.net/11287/623091
https://doi.org/10.1093/ecco-jcc/jjad182

المؤلفون: Liu, Z., Alexander, J. L., Le, K., Zhou, X., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Lin, K. W., McFarlane, L. R., Constable, L., Seoane, R. C., Anand, N., Bewshea, C., Nice, R., D'Mello, A., Jones, G. R., Balarajah, S., Fiorentino, F., Sebastian, S., Irving, P. M., Hicks, L. C., Williams, H. R., Kent, A. J., Linger, R., Parkes, M., Kok, K., Patel, K. V., Teare, J. P., Altmann, D. M., Boyton, R. J., Hart, A. L., Lees, C. W., Goodhand, J. R., Kennedy, N. A., Pollock, K. M., Ahmad, T., Powell, N.

مصطلحات موضوعية: Breakthrough infection, Inflammatory bowel disease, Infliximab, SARS-CoV-2, Tofacitinib

Relation: https://linkinghub.elsevier.com/retrieve/pii/S2589-5370(23)00426-1; Liu Z, Alexander JL, Le K, Zhou X, Ibraheim H, Anandabaskaran S, et al. Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study. EClinicalMedicine. 2023;64:102249.; EClinical Medicine; PMC10570718; https://hdl.handle.net/11287/623062

الاتاحة: https://hdl.handle.net/11287/623062
https://doi.org/10.1016/j.eclinm.2023.102249

المؤلفون: Gros, B, Constantine-Cooke, N, Kennedy, J, Elford, A T, O’Hare, C, Noble, C, Jones, G R, Arnott, I D, Plevris, N, Lees, C W

المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i102-i103 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0057
https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i102/56347882/jjad212.0057.pdf

المؤلفون: Scott, J, Thompson, E, Cheng, Z, David, M, Gordon, D, Medive-Tapia, L, Jones, G R, Hall, R, Chuah, S, Drury, B, Rossi, A, Shabat, D, Ho, G T, Vendrell, M

المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i267-i268 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0147
https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i267/56347790/jjad212.0147.pdf

المؤلفون: Gros, B, Ross, H, Nwabueze, M, Constantine-Cooke, N, Derikx, L A, Lyons, M, O'Hare, C, Noble, C, Arnott, I D, Jones, G R, Lees, C W, Plevris, N

المصدر: Journal of Crohn's and Colitis ; volume 18, issue Supplement_1, page i1592-i1594 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjad212.0990
https://academic.oup.com/ecco-jcc/article-pdf/18/Supplement_1/i1592/56349992/jjad212.0990.pdf

المؤلفون: Jones, G. R., Spencer, J. W.

المصدر: Advanced Chromatic Monitoring ; page 89-92 ; ISBN 9780367815202

الاتاحة: http://dx.doi.org/10.1201/9780367815202-12

المؤلفون: Jones, G. R., Sufian, A. T., Smith, D. H.

المصدر: Advanced Chromatic Monitoring ; page 15-19 ; ISBN 9780367815202

الاتاحة: http://dx.doi.org/10.1201/9780367815202-2

المؤلفون: Sufian, A. T., Jones, G. R.

المصدر: Advanced Chromatic Monitoring ; page 27-30 ; ISBN 9780367815202

الاتاحة: http://dx.doi.org/10.1201/9780367815202-4

المؤلفون: Sufian, A. T., Jones, G. R., Shabeer, H. M.

المصدر: Advanced Chromatic Monitoring ; page 39-46 ; ISBN 9780367815202

الاتاحة: http://dx.doi.org/10.1201/9780367815202-6

المؤلفون: Sufian, A. T., Jones, G. R.

المصدر: Advanced Chromatic Monitoring ; page 31-38 ; ISBN 9780367815202

الاتاحة: http://dx.doi.org/10.1201/9780367815202-5